Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Hepatic Circulation Regulation in Liver Resection
NCT04010669Phase 3Unknown
- Sponsor
- Laiko General Hospital
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of somatostatin in Portal Hypertension (PH), sponsored by Laiko General Hospital. Status: unknown.
02
Drugs
somatostatin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT04010669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04010669.